Suárez, C, Torras, OR, Barrera, RM, Sánchez, AR, Palacios, GA, Manshino, AMB, Núñez, NF, Vidal, MJM, Carbonero, IG, Calvo, OF, Sarrió, RG, Herrero, GC, Afonso, JA, Fita, MJJ, Padró, JG, Quintela, ML, Rodriguez-Vida, A, Perez, CH, Colmenero, AM, Martin, RC, de España, CG, Palau, CM, Ortega, EM, Gallardo, E. Effectiveness and Safety of Cabozantinib Treatment in Patients with Advanced Renal Cell Carcinoma in Spanish and Portuguese Real-world Practice: The SOGUG-SPRWEC Study. Clinical Genitourinary Cancer. 2025; 23(5)DOI:10.1016/j.clgc.2025.102402. PMID:40830022. IF:2.700(Q2/3D).

Palmerini, E, Meazza, C, Tamburini, A, Márquez-Vega, C, Bisogno, G, Fagioli, F, Ferraresi, V, Milano, GM, Coccoli, L, Rubio-San-Simón, A, Gallego, O, Riestra, MEL, Manzitti, C, Mora, J, Vaz-Salgado, MA, Luksch, R, Mata, C, Pierini, M, Carretta, E, Cesari, M, Paioli, A, Marrari, A, Scotlandi, K, Serra, M, Asaftei, SD, Gambarotti, M, Picci, P, Ferrari, S, Valverde, C, Ibrahim, T, Broto, JM. Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials. JOURNAL OF CLINICAL ONCOLOGY. 2025; 43(28)DOI:10.1200/JCO-25-00210. PMID:40825172. IF:41.900(Q1/1D).

Tibau, A, Romano, A, Liu, ITT, Han, J, Cliff, ERS, Kesselheim, AS. Assessing outcomes emerging after conversion to regular approval for cancer drug indications granted accelerated approval, 1992-2021. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2025; 117(10)DOI:10.1093/jnci/djaf195. PMID:40690366. IF:7.200(Q1/2D).

López-Fernández, A, Pardo, M, Pérez-Ballestero, E, Darder, E, Alfonso, R, Torres-Esquius, S, Garcés, VN, Cajal, TRY, Brunet, J, Balmaña, J. Exploring communication preferences for disclosing breast cancer risk in women with a family history. Journal of Genetic Counseling. 2025; 34(5)DOI:10.1002/jgc4.70114. PMID:40965181. IF:1.900(Q2/5D).

Fumagalli, C, Mozos, A, Szafranska, J, Orellana, R. Metastatic melanoma mimicking an angiomatoid fibrous histiocytoma. Revista Espanola De Patologia. 2025; 58(4)DOI:10.1016/j.patol.2025.100841. PMID:40902304. IF:(Q/D).

Recalde-Percaz, L, de la Guia-lopez,, Linzoain-Agos, P, Noguera-Castells, A, Rodrigo-Faus, M, Jauregui, P, Lopez-Plana, A, Fernández-Nogueira, P, Iniesta-González, M, Cueto-Remacha, M, Manzano, S, Alonso, R, Moragas, N, Baquero, C, Palao, N, Dalla, F, Avilés-Jurado, FX, Vilaseca,, León-Vintró, X, Camacho, M, Fuster, G, Alcaraz, J, Aguirre-Ghiso, J, Gascón, P, Porras, A, Gutiérrez-Uzquiza, A, Carbó, N, Bragado, P. Neuropilin-2 upregulation by stromal TGFß1 induces lung disseminated tumor cells dormancy escape and promotes metastasis outgrowth. NEOPLASIA. 2025; 68DOI:10.1016/j.neo.2025.101220. PMID:40848614. IF:7.700(Q1/2D).

Fasanella, MG, Mozos, A, Briones, J, Nomdedeu, JF, Novelli, S. Evaluation of Clinical Outcomes and Treatment Complications in Hairy Cell Leukemia: A Single-Center Retrospective Analysis. Cancer Reports. 2025; 8(10)DOI:10.1002/cnr2.70356. PMID:41031578. IF:(Q/D).

Puig Campmany M, Martin-Fumadó C, Pujol-Robinat A, Arimany-Manso J. Clinical-assistance and medical-legal aspects of the use of electric weapons.. MEDICINA CLINICA. 2025; 165(4)DOI:10.1016/j.medcli.2025.107121. PMID:40680410. IF:(Q/D).